| Active substance | per 1ml Dipeptiven® |
| N(2)-L-alanyl-L-glutamine | 200 mg (= 82.0 mg L-alanine, 134.6 mg L-glutamine) |
Dipeptiven®
(N(2)-L-alanyl-L-glutamine)
- Filename
- Macronutrient Prescribing Information.pdf
- Size
- 209 KB
- Format
Details
- Composition
- Features
- Indication
- Presentation and order codes
- In adults, Dipeptiven is administered in-parallel with parenteral nutrition or enteral nutrition or a combination of both. Duration of use should not exceed three weeks
- Dipeptiven is an infusion solution concentrate which is not designed for direct administration. Please consult the SmPC for administration instructions
- Safety and efficacy in children have not been established
Dipeptiven is indicated as part of a clinical nutrition regimen in patients in hypercatabolic and/or hypermetabolic states. It should be given together with parenteral or enteral nutrition or a combination of both
| Dipeptiven | ||
|---|---|---|
| Item Code | Unit Size | Case Qty |
| 1142031 | 100ml | 10 |
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk Adverse events should also be reported to Fresenius Kabi Limited. Email: Pharmacovigilance.GB@fresenius-kabi.com
GB-Dipep-2400001 January 2025